echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: TMAO level is associated with recurrence of ischemic stroke (CNSR-III study)

    Stroke: TMAO level is associated with recurrence of ischemic stroke (CNSR-III study)

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

    Trimethylamine oxide ( Trimethylamine N-oxide, of TMAO ) is one enteric flora related metabolites derived, was recently found to be a potential risk factor for cardiovascular disease and other chronic diseases , mainly by increasing macrophage cholesterol Accumulation and formation of foam cells, promoting the inflammatory reaction of the arterial wall and increasing the hyperresponsiveness of platelets, etc.
    play a role in causing atherosclerosis
    .


    Not only that, research has also found that TMAO is highly related to diseases such as diabetes, hypertension and even atrial fibrillation


    Trimethylamine oxide ( Trimethylamine N-oxide, of TMAO ) is one enteric flora related metabolites derived, was recently found to be a potential risk factor for cardiovascular disease and other chronic diseases , mainly by increasing macrophage cholesterol Accumulation and formation of foam cells, promoting the inflammatory reaction of the arterial wall and increasing the hyperresponsiveness of platelets, etc.


    The study included 10756 patients with ischemic stroke/TIA in CNSR-III with baseline TMAO values.
    The patients were divided into 4 groups according to their plasma TMAO levels (Q1: <1.
    17umol/L; Q2: 1.
    17-1.
    75umo/L ; Q3: 1.
    75-2.
    63umol/L; Q4:> 2.
    63umol/L)
    .


    The main outcome of the study was the recurrence of stroke within 1 year of follow-up


    The study included 10756 patients with ischemic stroke/TIA in CNSR-III with baseline TMAO values.


    As a highly recurring and highly disabling disease, ischemic stroke actively discovers more potential risk factors for stroke recurrence, which is essential for precise treatment and secondary prevention of ischemic stroke based on different etiological classifications
    .


    This study shows that plasma TMAO is an independent predictor of the risk of stroke recurrence within 1 year, but there are differences in its impact on stroke patients with different TOAST classifications.


    As a highly recurring and highly disabling disease, ischemic stroke actively discovers more potential risk factors for stroke recurrence, which is essential for precise treatment and secondary prevention of ischemic stroke based on different etiological classifications


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.